SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-012695
Filing Date
2021-03-12
Accepted
2021-03-12 08:30:24
Documents
5
Period of Report
2021-05-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A evok-pre14a_20210505.htm PRE 14A 820576
2 GRAPHIC gzcgr31z3jx2000004.jpg GRAPHIC 297735
3 GRAPHIC gzcgr31z3jx2000003.jpg GRAPHIC 462228
4 GRAPHIC gzcgr31z3jx2000002.jpg GRAPHIC 16465
5 GRAPHIC gzcgr31z3jx2000001.jpg GRAPHIC 15521
  Complete submission text file 0001564590-21-012695.txt   1912533
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36075 | Film No.: 21735520
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences